Strong Support
descriptive
The level of protective antibodies generated by the recombinant zoster vaccine in Indian adults over 50 is similar to what has been seen in people from other countries, indicating the vaccine works...
73
0
Evidence from Studies
Supporting (1)
73
Community contributions welcome
73
Immune response and safety of the adjuvanted recombinant zoster vaccine in adults 50 years of age and older in India: A randomized phase 3 trial.
Randomized Controlled Trial
Human
2025 Mar 19Contradicting (0)
0
Community contributions welcome
No contradicting evidence found
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.